Home 2018
Archives
Clinical Upstaging of NSCLC Seen With Each Progressive Week
For clinical stage 1 NSCLC, 21.7 percent of patients upstaged after 1 week; 31.5 percent after 8 weeks
Improved Outcomes With Public Reporting of CABG Data
Decrease in observed and expected mortality rates, risk factor rates from 2002 to 2014 in Massachusetts
AAN: New Drug May Help Infants With Spinal Muscular Atrophy
RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose
AAN: Cerliponase Alfa Beneficial for Form of Batten’s Disease
Reduced decline in motor, language function in children with CLN2 compared with historical controls
Drug-Related Endocarditis Cases Up From 2007 to 2015
Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use
Study Finds 31 Percent Use No Opioids After Surgery
At discharge, 92.2 percent of patients received an opioid prescription; nearly 63 percent unused
Eight Factors Predict Pain After Spine Surgery
Post-op pain strongly linked to number of classes of non-opioid analgesics used, remifentanil use
AAN: Neuromodulation Therapy Gives Relief From Hand Tremor
Non-invasive neuromodulation therapy using a custom stimulation pattern safe for essential tremor
Less Pain Post TKA With Addition of Peripheral Nerve Blocks
Lower numeric rating scale pain scores on ambulation on postoperative days zero, one, and two
AAN: New Drug May Help Infants With Spinal Muscular Atrophy
RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose
